Group B streptococcus vaccines: one step further
- PMID: 32891192
- PMCID: PMC7470735
- DOI: 10.1016/S1473-3099(20)30451-5
Group B streptococcus vaccines: one step further
Comment on
-
Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial.Lancet Infect Dis. 2021 Feb;21(2):263-274. doi: 10.1016/S1473-3099(20)30478-3. Epub 2020 Sep 3. Lancet Infect Dis. 2021. PMID: 32891191 Free PMC article. Clinical Trial.
References
-
- Absalon J, Segall N, Block SL. Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded trial. Lancet Infect Dis. 2020 doi: 10.1016/S1473-3099(20)30478-3. published online Sept 3. - DOI - PMC - PubMed
-
- Zürn K, Lander F, Hufnagel M, Monecke S, Berner R. Microarray analysis of group B streptococci causing invasive neonatal early- and late-onset infection. Pediatr Infect Dis J. 2020;39:449–453. - PubMed
-
- Baker CJ, Rench MA, Edwards MS, Carpenter RJ, Hays BM, Kasper DL. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med. 1988;319:1180–1185. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
